S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine (Q73199972)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine |
scientific article published on 01 December 2000 |
Statements
S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine (English)
Millan MJ
Lejeune F
Gobert A
Brocco M
Auclair A
Bosc C
Rivet JM
Lacoste JM
Cordi A
1 December 2000